1887

Journal of General Virology header logo

Volume 73, Issue 3

A vaccinia serine protease inhibitor which prevents virus-induced cell fusion Free

Abstract

A deletion mutant lacking the non-essential vaccinia virus gene K2L, a member of the serine protease inhibitor superfamily, was constructed. This virus replicates in all cell types tested and its virulence and immunogenicity are comparable to those of the parent virus in intranasally inoculated mice. However, in a variety of cell lines the cytopathic effect of the deletion mutant (vKL4) is markedly different from that caused by the parent virus: the absence of K2L in infected cells results in extensive polykaryocytosis. Reinsertion of the K2L gene into vKL4 abolishes this fusion activity, thus confirming that the polykaryocytosis is the result of the deletion of K2L rather than of spontaneous mutations elsewhere in the genome, and that in cells infected with the WR strain of vaccinia virus the K2L gene product prevents fusion. The cell type-specific polykaryocytosis induced by vKL4 is apparent at late times post-infection, occurs from within and requires the synthesis of at least one late virus protein. Other vaccinia virus proteins known to be involved in fusion of infected cells are a 14K membrane protein which is required for fusion, and the haemagglutinin which prevents fusion. The haemadsorption properties of cells infected with the parent virus and the deletion mutant were indistinguishable: both haemadsorbed chicken erythrocytes. A monoclonal antibody against the 14K protein inhibited fusion of vKL4-infected cells, thus demonstrating that in addition to the absence of the K2L gene product, the 14K protein is required for fusion to occur.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1992
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-3-549
1992-03-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/3/JV0730030549.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-3-549&mimeType=html&fmt=ahah

References

  1. Blackman K. E., Bubel H. C. 1972; Origin of the vaccinia virus hemagglutinin. Journal of Virology 9:290–296
     [Google Scholar]
  2. Boursnell M. E. G., Foulds I. J., Campbell J. I., Binns M. M. 1988; Non-essential genes in the vaccinia virus HindIII K fragment: a gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen. Journal of General Virology 69:2995–3003
     [Google Scholar]
  3. Boyle D. B., Coupar B. E. H. 1988; A dominant selectable marker for the construction of recombinant poxviruses. Gene 65:123–128
     [Google Scholar]
  4. Brown C. K., Turner P. C., Moyer R. W. 1991; Molecular characterization of the vaccinia virus hemagglutinin gene. Journal of Virology 65:3598–3606
     [Google Scholar]
  5. Carrell R. W., Pemberton P. A., Boswell D. R. 1987; The serpins: evolution and adaptation in a family of protease inhibitors. Cold Spring Harbor Symposia on Quantitative Biology 52:527–535
     [Google Scholar]
  6. Chua T. P., Smith C. E., Reith R. W., Williamson J. D. 1990; Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues. Immunology 69:202–208
     [Google Scholar]
  7. Clague M. J., Schoch C., Blumenthal R. 1991; Delay time for influenza virus hemagglutinin-induced membrane fusion depends on hemagglutinin surface density. Journal of Virology 65:2402–2407
     [Google Scholar]
  8. Ellens H., Bentz J., Mason D., Zhang F., White J. 1990; Fusion of influenza hemagglutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochemistry 29:9697–9707
     [Google Scholar]
  9. Falkner F. G., Moss B. 1990; Transient dominant selection of recombinant vaccinia viruses. Journal of Virology 64:3108–3111
     [Google Scholar]
  10. Gong S., Lai C., Esteban M. 1990; Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 178:81–91
     [Google Scholar]
  11. Henis Y. I., Herman-Barhom Y., Aroeti B., Gutman O. 1989; Lateral mobility of both envelope proteins (F and HN) of Sendai virus in the cell membrane is essential for cell-cell fusion. Journal of Biological Chemistry 264:17119–17125
     [Google Scholar]
  12. Ichihashi Y. 1977; Vaccinia-specific hemagglutinin. Virology 76:527–538
     [Google Scholar]
  13. Ichihashi Y., Matsumoto S., Dales S. 1971; Biogenesis of poxviruses: interrelationship between hemagglutinin production and polykaryocytosis. Virology 46:533–543
     [Google Scholar]
  14. Ichihashi Y., Matsumoto S., Dales S. 1971; Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology 46:507–532
     [Google Scholar]
  15. Kotwal G. J., Moss B. 1989; Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. Journal of Virology 63:600–606
     [Google Scholar]
  16. Mackett M., Smith G. L., Moss B. 1984; General method for the production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
     [Google Scholar]
  17. Mackett M., Smith G. L., Moss B. 1985; The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach pp 191–211 Edited by Glover D. M. Oxford: IRL Press;
     [Google Scholar]
  18. Palumbo G. J., Pickup D. J., Fredrickson T. N., McIntyre L. J., Buller R. M. L. 1989; Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology 172:262–273
     [Google Scholar]
  19. Payne L. G. 1979; Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus. Journal of Virology 31:147–155
     [Google Scholar]
  20. Payne L. G., Kristensson K. 1985; Effect of glycosylation inhibitors on the release of enveloped vaccinia virus. Journal of Virology 41:367–375
     [Google Scholar]
  21. Payne L. G., Norrby E. 1976; Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. Journal of General Virology 32:63–72
     [Google Scholar]
  22. Perkus M. E., Panicali D., Mercer S., Paoletti E. 1986; Insertion and deletion mutants of vaccinia virus. Virology 152:285–297
     [Google Scholar]
  23. Perkus M. E., Limbach K., Paoletti E. 1989; Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. Journal of Virology 63:3829–3836
     [Google Scholar]
  24. Perkus M. E., Goebel S. J., Davis S. W., Johnson G. P., Norton E. K., Paoletti E. 1991; Deletion of 55 open reading frames from the termini of vaccinia virus. Virology 180:406–410
     [Google Scholar]
  25. Pickup D. J., Ink B. S., Hu W., Ray C. A., Joklik W. K. 1986; Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proceedings of the National Academy of Sciences, U.S.A 83:7698–7702
     [Google Scholar]
  26. Rodriguez J. F., Esteban M. 1987; Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. Journal of Virology 61:3550–3554
     [Google Scholar]
  27. Rodriguez J. F., Smith G. L. 1990; IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Research 18:5347–5351
     [Google Scholar]
  28. Rodriguez J. F., Janezcko R., Esteban M. 1985; Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus. Journal of Virology 56:482–488
     [Google Scholar]
  29. Rodriguez J. F., Paez E., Esteban M. 1987; A 14000-M r envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers. Journal of Virology 61:395–404
     [Google Scholar]
  30. Ross D. S., Duchala C. S., Stephensen C. B., Holmes K. V., Choppin P. W. 1990; Control of virus-induced cell fusion by host cell lipid composition. Virology 175:345–357
     [Google Scholar]
  31. Seki M., Oie M., Ichihashi Y., Shida H. 1990; Hemadsorption and fusion inhibition activities of hemagglutinin analyzed by vaccinia virus mutants. Virology 175:372–384
     [Google Scholar]
  32. Shida H., Dales S. 1981; Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecule. Virology 111:56–72
     [Google Scholar]
  33. Shida H., Dales S. 1982; Biogenesis of vaccinia: molecular basis for the hemagglutinin-negative phenotype of IHD-W strain. Virology 117:219–237
     [Google Scholar]
  34. Shida H., Matsumoto S. 1983; Analysis of the hemagglutinin glycoprotein from mutants of vaccinia virus that accumulates on the nuclear envelope. Cell 33:423–434
     [Google Scholar]
  35. Smith G. L., Mackett M., Moss B. 1983; Infectious vaccinia virus recombinants that express hepatitis B virus suface antigen. Nature, London 302:490–495
     [Google Scholar]
  36. Smith G. L., Howard S. T., Chan Y. S. 1989; Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. Journal of General Virology 70:2333–2343
     [Google Scholar]
  37. Smith G. L., Chan Y. S., Howard S. T. 1991; Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. Journal of General Virology 72:1349–1376
     [Google Scholar]
  38. Tomley F., Binns M., Campbell J., Boursnell M. 1988; Sequence analysis of an 11.2 kilobase, near-terminal, Bam HI fragment of fowlpox virus. Journal of General Virology 69:1025–1040
     [Google Scholar]
  39. Upton C., Macen J. L., Wishart D. S., McFadden G. 1990; Myxoma virus and malignant rabbit fibroma virus encode a serpin-like protein important for virus virulence. Virology 179:618–631
     [Google Scholar]
  40. Weintraub S., Dales S. 1974; Biogenesis of poxviruses: genetically controlled modifications of structural and functional components of the plasma membrane. Virology 60:96–127
     [Google Scholar]
  41. Zhou J., Crawford L., McLean L., Sun X.-Y., Stanley M., Almond N., Smith G. L. 1990; Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes. Journal of General Virology 71:2185–2190
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-3-549
Loading
A vaccinia serine protease inhibitor which prevents virus-induced cell fusion
J. Gen. Virol. 73, 549 (1992); https://doi.org/10.1099/0022-1317-73-3-549
/content/journal/jgv/10.1099/0022-1317-73-3-549
/content/journal/jgv/10.1099/0022-1317-73-3-549
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error